LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 3 filers reported holding LEGEND BIOTECH CORP in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,713,314 | -33.1% | 129,718 | -31.1% | 0.01% | -30.8% |
| Q2 2023 | $13,019,958 | +131.0% | 188,210 | +61.0% | 0.01% | +85.7% |
| Q1 2023 | $5,636,328 | +56.6% | 116,893 | +62.1% | 0.01% | +75.0% |
| Q4 2022 | $3,600,279 | +47.4% | 72,126 | +20.5% | 0.00% | 0.0% |
| Q3 2022 | $2,442,000 | -18.4% | 59,860 | +10.0% | 0.00% | 0.0% |
| Q2 2022 | $2,992,000 | +74.0% | 54,398 | +15.0% | 0.00% | +100.0% |
| Q1 2022 | $1,720,000 | +15.4% | 47,306 | +48.0% | 0.00% | +100.0% |
| Q4 2021 | $1,490,000 | – | 31,953 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FengHe Fund Management Pte. Ltd. | 997,714 | $36,257,000 | 13.28% |
| JOHNSON & JOHNSON | 1,629,173 | $59,204,000 | 11.19% |
| Paradigm Biocapital Advisors LP | 831,728 | $30,225,000 | 7.99% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,100,542 | $39,994,000 | 5.54% |
| HHLR ADVISORS, LTD. | 6,936,617 | $252,077,000 | 5.26% |
| Old Well Partners, LLC | 79,700 | $2,896,000 | 1.94% |
| Parkman Healthcare Partners LLC | 120,473 | $4,378,000 | 1.28% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 4,500 | $5,632,000 | 1.27% |
| AtonRa Partners | 50,928 | $1,851,000 | 1.00% |
| Avidity Partners Management LP | 1,095,000 | $39,792,000 | 0.83% |